CyGene Laboratories Taps The Better Image Company to Help Build Identity and Market Products

ARCHIVED 2002–2016: Originally distributed via the eWire press wire service. Preserved as historical record.

SUBSCRIBE/UNSUBSCRIBE |

Conservation & Wildlife

Corporate Responsibility

Science & Technology

Syndication Partners

**************************************************************************

E-WIRE PRESS RELEASE E-WIRE PRESS RELEASE E-WIRE PRESS RELEASE

**************************************************************************

For Immediate Release

CyGene Laboratories Taps The Better Image Company to Help Build Identity and Market Products

CORAL SPRINGS, FLORIDA, Oct. 16 -/E-Wire/-- CyGene Laboratories, Inc. (OTCBB:CYGE), a pioneering company in the rapidly-growing field of genetic profiling and diagnostic testing, has retained the services of The Better Image Company, a marketing firm based in Sarasota, Florida. The firm will assist CyGene in the marketing of products that use the company's proprietary biotechnology for various commercial applications.

"We're delighted that The Better Image Company will be assisting us in our efforts to bring several innovative CyGene products to market," says Martin Munzer, President & CEO of CyGene Laboratories, Inc. "Charles Bird and his creative team at The Better Image Company have been instrumental in positioning a number of emerging growth companies in a wide range of fields. The Better Image Company will work with CyGene to help devise a multi-faceted approach to commercializing its biotechnology. The companies will explore various strategies for capitalizing on the enormous growth opportunities in genetic profiling and diagnostic testing.

"We believe that CyGene's proprietary biotechnology and the marketing skills of The Better Image Company fit very well together," reflects Charles E. Bird, President of The Better Image Company.

"By 2008 the market for genetic profiling is projected to be $11 billion in the United States and $25 billion worldwide. A number of companies are entering this market or expanding their presence in itâbut CyGene's biotechnology is the most advanced. We are already working with the company to help develop its strategies, and the CyGene/Better Image partnership is producing great results."

About CyGene Laboratories

CyGene Laboratories, based in Coral Springs, Florida, is dedicated to developing its proprietary genetic profiling and diagnostic testing methods for the medical marketplace, to become a global leader in broad-based biotechnology applications.

Since 1995 the company has been developing proprietary and automated DNA and RNA testing systems for the screening, monitoring and diagnosis of human, veterinary and plant diseases. CyGene's Haystack ProcessingÃ platform supports the highest possible levels of sensitivity and specificity available in the field of molecular diagnostics. The company has also developed AGENDAÃ, a proprietary automated genomic analysis method. Please visit the website at www.cygene.com.

About The Better Image Company

The Better Image Company (BIC), under the direction of its founder and president Charles E. Bird, has a history of producing innovative marketing and tangible results, including corporate identities, brand strategies, product introductions and campaigns for Fortune 500 companies. The company also has helped position and package start-up and emerging growth companies for more than three decades.

BIC's accomplishments in creating and developing financial packages have resulted in significant capital formation for a number of early-stage clients.

Safe Harbor The statements contained in this news release relating to the bringing of innovative products to the market, devising an approach to commercialize its products and the forecasted market for genetic profiling are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Additionally words such as "seek" "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions are forward-looking statements within the meaning of the Act. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. Some or all of the results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include, but are not limited to, CyGene's raising sufficient funds to support its development, marketing efforts and corporate overhead, its ability to attract technical employees and the ability of CyGene's management to grow its business with limited assistance. CyGene Laboratories has no duty and undertakes no obligation to update such statements. You should independently investigate and fully understand all risks before making investment decisions.

CyGene Laboratories, Inc.

Martin Munzer, [REDACTED-PHONE] x 4403

The Better Image Company

Charles E. Bird, [REDACTED-PHONE]

**************************************************************************

To Transmit Your News Over E-Wire, visit http://www.ewire.com or

call 1-[REDACTED-PHONE]. E-Wire Is Broadcast To Millions Of Readers Worldwide

**************************************************************************